Scientific publications
Advanced MR Techniques for Preoperative Glioma Characterization: Part 2
Gilbert Hangel 1 2 3 4 , Bárbara Schmitz-Abecassis 5 6 , Nico Sollmann 7 8 9 , Joana Pinto 10 , Fatemehsadat Arzanforoosh 11 , Frederik Barkhof 12 13 , Thomas Booth 14 15 , Marta Calvo-Imirizaldu 16 , Guilherme Cassia 17 , Marek Chmelik 18 , Patricia Clement 19 20 , Ece Ercan 5 , Maria A Fernández-Seara 16 21 , Julia Furtner 22 23 , Elies Fuster-Garcia 24 , Matthew Grech-Sollars 25 26 , N Tugay Guven 27 , Gokce Hale Hatay 27 , Golestan Karami 14 , Vera C Keil 12 28 , Mina Kim 29 , Johan A F Koekkoek 30 31 , Simran Kukran 32 33 , Laura Mancini 26 34 , Ruben Emanuel Nechifor 35 , Alpay Özcan 36 , Esin Ozturk-Isik 27 , Senol Piskin 37 , Kathleen M Schmainda 38 , Siri F Svensson 39 40 , Chih-Hsien Tseng 6 41 , Saritha Unnikrishnan 42 43 , Frans Vos 6 11 41 , Esther Warnert 11 , Moss Y Zhao 44 45 , Radim Jancalek 46 47 , Teresa Nunes 48 , Lydiane Hirschler 49 , Marion Smits 6 11 50 , Jan Petr 51 , Kyrre E Emblem 39
Abstract
Preoperative clinical MRI protocols for gliomas, brain tumors with dismal outcomes due to their infiltrative properties, still rely on conventional structural MRI, which does not deliver information on tumor genotype and is limited in the delineation of diffuse gliomas.
The GliMR COST action wants to raise awareness about the state of the art of advanced MRI techniques in gliomas and their possible clinical translation.
This review describes current methods, limits, and applications of advanced MRI for the preoperative assessment of glioma, summarizing the level of clinical validation of different techniques. In this second part, we review magnetic resonance spectroscopy (MRS), chemical exchange saturation transfer (CEST), susceptibility-weighted imaging (SWI), MRI-PET, MR elastography (MRE), and MR-based radiomics applications.
The first part of this review addresses dynamic susceptibility contrast (DSC) and dynamic contrast-enhanced (DCE) MRI, arterial spin labeling (ASL), diffusion-weighted MRI, vessel imaging, and magnetic resonance fingerprinting (MRF). EVIDENCE LEVEL: 3. TECHNICAL EFFICACY: Stage 2.
CITATION J Magn Reson Imaging. 2023 Mar 13. doi: 10.1002/jmri.28663
Our authors
